Publications
91
Citations
1,205
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1985
Melissa J. Rose is a pediatric hematologist whose work focuses on blood disorders in children, including sickle cell disease, immune thrombocytopenia (a condition causing low platelet counts), bone marrow failure, and rare blood cell abnormalities. Her research also extends to clinical care models, multidisciplinary treatment approaches for immune dysregulation disorders, and medical education, particularly the training of pediatric hematology/oncology fellows. Note that a few unrelated publications on molten salt chemistry appear in this record, likely due to author-name overlap with a different researcher.
Publication output has been relatively steady over the last decade, averaging about 7 papers per year over the last five years, with some year-to-year fluctuation but no clear long-term upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation
Pediatric Blood & Cancer · 2026
- Bone Marrow Morphology in Hereditary Thrombocytosis May Show Features of Myeloproliferative Neoplasms: A Case Report of a Child with Homozygous <i>MPL</i> Baltimore Germline Variant and Review of Literature
Pediatric and Developmental Pathology · 2026
- Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation
Frontiers in Immunology · 2025
- Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype
Pediatric Blood & Cancer · 2025
- Bilateral Native Nephrectomy as a Successful Treatment for Persistent Polycythemia in a Pediatric Kidney Transplant Recipient: Case Report
Pediatric Transplantation · 2025
- Paediatric Gastrointestinal Procedural Patterns in New York City During the <scp>COVID</scp> ‐19 Pandemic
Journal of Paediatrics and Child Health · 2025
- Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation
2025
- Marrow-ly we learn along: A needs assessment of the educational needs of pediatric and young adult patients with bone marrow failure
Blood · 2025
- Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States
Pediatric Blood & Cancer · 2024
- Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia
Blood Advances · 2024
- Storming the castle: A case report of multi-system dysregulation in a child with Castleman disease
2024
- Hematology
2024
- A Longitudinal Review Comparing Absolute Neutrophil Counts of Children with Sickle Cell Disease with and without the Duffy Null Phenotype
Blood · 2024
- Complementary and Alternative Medicine (CAM) Use Reported Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry
Blood · 2024
- Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab
Blood · 2024
- Blood×21
- Pediatric Blood & Cancer×6
- American Journal of Hematology×4
- Blood Advances×3
- Journal of Allergy and Clinical Immunology×2
- Laura D. Stephens
Medicine · The Ohio State University
- Amanda Jacobson‐Kelly
Medicine · The Ohio State University
- Aikaterini Voulgaridou
Medicine · Indiana University
- Haripriya Sakthivel
Medicine · Purdue University West Lafayette
- Patrick G. Gallagher
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile